Skip to main navigation Skip to search Skip to main content

SBIR Phase I: A nano-optical imaging microendoscope for in vivo Imaging

Project: Research

Abstract & Details

Description

Award ID: 2432611

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will enable researchers to visualize the dynamics of the biological events in live animals. The product, the miniaturized optical imaging micro-endoscope, will change researchers current paradigm of only visualizing and exploring the superficial layers of tissue at a subcellular level. Visualizing the deeper layers of tissue in >1 mm depth at the subcellular level using the miniaturized optical imaging micro-endoscope will enable a range of discoveries in different areas of biomedical research. In the long term, the developed product can be utilized by physicians to improve the current standards of care in various medical applications. This Small Business Innovation Research (SBIR) Phase I project is developing a nanophotonic imaging microendoscope for in vivo imaging with minimal damage. Current optical microscopy imaging cannot be used for imaging beyond 1 mm depth. The current microendoscopes have a diameter larger than 0.5-1 mm, so they cause severe damage to the tissue when inserted into the tissue. The current microendoscopes cannot provide images in >1 mm depth since the damage to the tissue changes the whole tissue structure. Miniaturized microendoscopic tools with subcellular resolution are vital for deep tissue imaging (>1 mm). The product of this SBIR project will be 100 m diameter, a hair-size micro-endoscope allowing researchers and scientists to conduct their studies at >3 mm depth in a live animal. The state of the art of optical design and nanofabrication techniques will be utilized to make the miniaturized microendoscope. This project will lead to derisking the risks associated with the miniaturization of the optical microendoscope and enabling its usage for in vivo imaging. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

NSF Program Director: Henry Ahn
StatusClosed
Effective start/end date09/01/2407/31/26

Funding

  • SBIR Phase I: $275,000.00

Active Fiscal Year

  • FY2024
  • FY2026
  • FY2025

Start Fiscal Year

  • FY2024

TIP Programs

  • SBIR Phase I

Small Business

  • Yes

Key Technology Areas

  • Biotechnology
  • (confidence score: 100%)

Technology Foci

  • Medical Technology
  • (confidence score: 98%)

Congressional District at Award

  • District n. 08 of Maryland

Current Congressional District

  • District n. 08 of Maryland

United States

  • Maryland

Core Based Statistical Area (CBSA)

  • Washington-Arlington-Alexandria, DC-VA-MD-WV

County

  • County: Montgomery, MD

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint. Learn more about Elsevier's Fingerprint Engine here: https://beta.elsevier.com/products/elsevier-fingerprint-engine